Financial report according to IFRS as at 30 June 2018 individual
The doctors we believe in with Sopharma's support
Students in the specialty of pharmacy visited Sopharma
Notification on the terms and conditions for payment of the dividend for 2017
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that the Company will initiate dividend payment of the voted on the AGM held on June, 15 2018 dividend of 0.11 BGN on July, 23 2018.
The persons eligible for dividend are those present in the register of the Central Depository 14 days after the date of the AGM, i.e. June, 29 2018.
Sales revenues for June 2018
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for June 2018 the Company recorded a decrease of sales revenues of 22% compared to the same month of 2017, including 2% decrease of domestic sales and a decrease of 34% of export sales.
For the first six months of this year, revenues from sales of products decreased by 8% compared to the same period of 2017, including 6% decrease of domestic sales and 10% decrease of export sales.
Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of June, 29 2018
Notification for acquisition of own shares